Exploring the Efficacy of the Traditional Chinese Medicine Compound Formulas Qianlong Shutong Formula in the Treatment of Benign Prostatic Hyperplasia
Abstract
Objective: This study aimed to assess the efficacy of the compound formula Qianlong Shutong Formula (QLSTF) in the treatment of benign prostatic hyperplasia (BPH) and its impact on hepatic and renal function. This assessment was conducted through randomized controlled trials and animal experimentation. Methods: A total of 160 BPH patients aged between 50 and 70 years were randomly allocated into two groups: The tamsulosin hydrochloride sustained-release capsules group (n=80) and the QLSTF + tamsulosin hydrochloride sustained-release capsules group (n=80). Both groups received a 12-week treatment regimen. In the animal experiments, 12 Sprague Dawley rats were categorized into three groups: The control group (n=4), the model group (n=4), and the QLSTF group (n=4). The latter group received herbal treatment for a duration of 28 days. Results: The current results showed, substantial improvements were observed in the clinical symptoms and signs of BPH within both drug groups. Additionally, no adverse effects on hepatic or renal function were detected. The QLSTF group exhibited a total effective rate of 90.41%, while the control group recorded 77.33%. During the course of treatment, three patients experienced dizziness, and two patients reported nausea and reduced appetite. However, these adverse reactions subsided after a rest period of 4-6h. Conclusion: Our findings underscore the advantages and safety of orally administered QLSTF. In the treatment of BPH, the combined treatment…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 160 participants or records.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.